TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19318693

Group type: EXPERIMENTAL
Intervention: CP-690,550 15 mg twice daily
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo twice daily
Number of subjects: 34
Study: 19263563

Group type: EXPERIMENTAL
Intervention: Health promotion program
Number of subjects: 131

Group type: COMPARATOR
Intervention: Individual program
Number of subjects: 131
Study: 15458808

Group type: EXPERIMENTAL
Intervention: Chewing Gum (gum)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucose (25 g glucose drink)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mint Sweet (control for chewing gum)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water (control for glucose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chewing Gum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glucose
Number of subjects: 0
Study: 11270304

Group type: EXPERIMENTAL
Intervention: Terbinafine 1% solution applied twice daily for 1 week
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Terbinafine 1% solution applied once daily for 1 week
Number of subjects: 219

Group type: COMPARATOR
Intervention: Vehicle control applied twice daily for 1 week
Number of subjects: 219

Group type: COMPARATOR
Intervention: Vehicle control applied once daily for 1 week
Number of subjects: 219
Study: 9639372

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of reduced glutathione (GSH, 50 mg/min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 26
Study: 8080601

Group type: EXPERIMENTAL
Intervention: General health and lifestyle questionnaire with alcohol questions embedded
Number of subjects: 182

Group type: COMPARATOR
Intervention: Straight alcohol screening questionnaire
Number of subjects: 182
Study: 2760247

Group type: EXPERIMENTAL
Intervention: 100 ml of 10 mM flurbiprofen solution in buffered preservative
Number of subjects: 24

Group type: COMPARATOR
Intervention: Preservative only (control)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Further 3 irrigations of flurbiprofen at intervals of 2 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Buffered preservative solution (control)
Number of subjects: 24
Study: 1000999

Group type: EXPERIMENTAL
Intervention: Dothiepin (75 mg once daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Amitriptyline (25 mg 3-times a day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Dothiepin
Number of subjects: 48

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 48
Study: 30633084

Group type: EXPERIMENTAL
Intervention: Physical Activity
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 658

Group type: EXPERIMENTAL
Intervention: Mediation Analysis
Number of subjects: 658
Study: 28114610

Group type: EXPERIMENTAL
Intervention: CSI-based intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional intervention
Number of subjects: 20
Study: 26717533

Group type: EXPERIMENTAL
Intervention: Cariprazine 3 mg/d
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Cariprazine 6 mg/d
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg/d
Number of subjects: 615

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615
Study: 23212806

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg daily (intensive therapy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pravastatin 40 mg (standard therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both treatment groups (intensive and standard therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing urine albumin concentration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urinary albumin concentration >300 mcg/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Albuminuria
Number of subjects: 0
Study: 21291377

Group type: EXPERIMENTAL
Intervention: Topical biphasic IFN α (1 MU/dose) applied twice daily for two weeks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Topical biphasic IFN α formulations (5, 15, and 40 MU/g) applied in a patch on healthy volunteers' upper inner arm
Number of subjects: 12
Study: 18183564

Group type: EXPERIMENTAL
Intervention: Sample sizes ranging from 10 to 40 per group
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: General sample size guidelines by type of aim
Number of subjects: 10
Study: 16911680

Group type: EXPERIMENTAL
Intervention: rabeprazole 10 mg q.d. for 6 weeks
Number of subjects: 112

Group type: COMPARATOR
Intervention: omeprazole 20 mg q.d. for 6 weeks
Number of subjects: 112
Study: 14600536

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 60
Study: 10874255

Group type: EXPERIMENTAL
Intervention: Metoprolol XL
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 8840059

Group type: EXPERIMENTAL
Intervention: Sevoflurane (1 MAC)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Isoflurane (1 MAC)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Fentanyl-diazepam-nitrous oxide
Number of subjects: 120
Study: 1385995

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6702817

Group type: EXPERIMENTAL
Intervention: Glycosylated hemoglobin concentration (HbA1)
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Fasting plasma glucose level
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Combinations of fasting plasma glucose and HbA1
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Plasma glucose one hour post oral glucose load
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Plasma glucose two hour post oral glucose load
Number of subjects: 2040

Group type: EXPERIMENTAL
Intervention: Full three-sample oral glucose tolerance test
Number of subjects: 2040
Study: 31950156

Group type: EXPERIMENTAL
Intervention: Nasal saline irrigations plus omega-3 supplementation
Number of subjects: 110

Group type: COMPARATOR
Intervention: Nasal saline irrigations
Number of subjects: 110
Study: 30813800

Group type: EXPERIMENTAL
Intervention: Single-shot ACB
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: 24-hour infusion ACB
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: 48-hour infusion ACB
Number of subjects: 156
Study: 29174316

Group type: EXPERIMENTAL
Intervention: PIKA vaccine accelerated regimen
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control vaccine classic regimen
Number of subjects: 126
Study: 26249836

Group type: EXPERIMENTAL
Intervention: MALDI‐TOF‐MS with WCX magnetic beads
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Classification model for RA diagnosis
Number of subjects: 50
Study: 24311766

Group type: EXPERIMENTAL
Intervention: Baseline 6-minute walk distance (6MWD) <250 m
Number of subjects: 748

Group type: EXPERIMENTAL
Intervention: 24-week decline in 6MWD >50 m
Number of subjects: 748

Group type: EXPERIMENTAL
Intervention: Inclusion of 6MWD data in the clinical prediction model
Number of subjects: 748
Study: 23033863

Group type: EXPERIMENTAL
Intervention: Posture-control insoles and ankle-foot orthoses (AFOs)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ankle-foot orthoses (AFOs) alone
Number of subjects: 24
Study: 18620746

Group type: EXPERIMENTAL
Intervention: Clearfil Esthetic Cement (Kuraray)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Rely x Unicem (3M ESPE)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Calibra (Densply Caulk)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Sandblasting with 125 microm aluminum‐oxide (Al(2)O(3)) particles
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Tribochemical silica coating using 50 microm Al(2)O(3) particles modified by silica
Number of subjects: 18

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 18
Study: 17353866

Group type: EXPERIMENTAL
Intervention: Thyroid hormone treatment
Number of subjects: 0
Study: 15471379

Group type: EXPERIMENTAL
Intervention: Monthly intravenous corticosteroids (1 g) during the six months postpartum
Number of subjects: 42

Group type: COMPARATOR
Intervention: No treatment after delivery
Number of subjects: 42
Study: 11477525

Group type: EXPERIMENTAL
Intervention: Cidofovir
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9574880

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 7891203

Group type: EXPERIMENTAL
Intervention: 60 mg of beta-carotene preparation (30 mg of all-trans beta-carotene and 30 mg of 9-cis beta-carotene)
Number of subjects: 0
Study: 2851172

Group type: EXPERIMENTAL
Intervention: RT + cis‐DDP 15 mg/m2 IV weekly
Number of subjects: 95

Group type: COMPARATOR
Intervention: RT alone (50 Gy)
Number of subjects: 95
Study: 29809030

Group type: EXPERIMENTAL
Intervention: Directional arrows
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Salient landmarks
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Map
Number of subjects: 58

Group type: COMPARATOR
Intervention: Path without additional visual stimuli (control condition)
Number of subjects: 58
Study: 27358261

Group type: EXPERIMENTAL
Intervention: Nutrition education and increased physical activity for pupils, lifestyle modification for parents, change in food items sold at schools' canteens (18 weeks duration)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Comparison group (no specific intervention details provided)
Number of subjects: 334
Study: 23802641

Group type: EXPERIMENTAL
Intervention: Z350 XT
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Z350 XT with fibers
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: P90
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: P90 with fibers
Number of subjects: 50

Group type: COMPARATOR
Intervention: Positive controls (cavities not restored)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Negative controls (no cavities prepared)
Number of subjects: 50
Study: 22692481

Group type: EXPERIMENTAL
Intervention: FATaintPHAT intervention
Number of subjects: 458
Study: 20128578

Group type: EXPERIMENTAL
Intervention: Topical prednisolone acetate 1% four times daily for 1 week
Number of subjects: 25

Group type: COMPARATOR
Intervention: No steroid therapy
Number of subjects: 25
Study: 17556693

Group type: EXPERIMENTAL
Intervention: Milk (extrinsically labeled (13C))
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Spinach (intrinsically labeled (15N))
Number of subjects: 20
Study: 15008696

Group type: EXPERIMENTAL
Intervention: Combined CABG on a beating heart and AAA repair
Number of subjects: 56

Group type: COMPARATOR
Intervention: CABG on a beating heart
Number of subjects: 56

Group type: COMPARATOR
Intervention: AAA repair
Number of subjects: 56
Study: 11816440

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 268

Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine (SP)
Number of subjects: 268
Study: 9892280

Group type: EXPERIMENTAL
Intervention: Ivermectin (annual, 3-monthly, and 6-monthly doses)
Number of subjects: 4072

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4072
Study: 8062508

Group type: EXPERIMENTAL
Intervention: Brain natriuretic peptide infusion at 0.4 pmol min‐1 kg‐1, doubling every 15 min to 6.4 pmol min‐1 kg‐1 for 30 min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide infusion at 0.75 pmol min‐1 kg‐1 for 3 h
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of atrial natriuretic peptide and brain natriuretic peptide infusion for 3 h
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control infusion (vehicle)
Number of subjects: 12
Study: 3376710

Group type: EXPERIMENTAL
Intervention: Hairspray
Number of subjects: 55

Group type: COMPARATOR
Intervention: Merckofix
Number of subjects: 55
Study: 30442868

Group type: EXPERIMENTAL
Intervention: ACTH (repository corticotropin injection) 80 U/1.73 m2 administered twice weekly for 6 months, followed by 40 U/1.73 m2 administered twice weekly for 6 months
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no relapse-preventing treatment)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ACTH treatment after dose reduction
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ACTH treatment
Number of subjects: 31
Study: 27789470

Group type: EXPERIMENTAL
Intervention: Topotecan plus carboplatin (TC)
Number of subjects: 550

Group type: COMPARATOR
Intervention: Standard therapy (PC, GC, PLDC)
Number of subjects: 550
Study: 25608275

Group type: EXPERIMENTAL
Intervention: Silk fabric briefs
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cotton briefs
Number of subjects: 20
Study: 23153742

Group type: EXPERIMENTAL
Intervention: Calcium fructoborate
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Resveratrol plus calcium fructoborate
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Resveratrol
Number of subjects: 166

Group type: COMPARATOR
Intervention: Usual medical care and treatment
Number of subjects: 166
Study: 20667439

Group type: EXPERIMENTAL
Intervention: Postoperative re‐transfusion of mediastinal shed blood (n=39)
Number of subjects: 77

Group type: COMPARATOR
Intervention: No autotransfusion (discarded mediastinal shed blood, n=38)
Number of subjects: 77
Study: 18986531

Group type: EXPERIMENTAL
Intervention: 7.5 mg prednisolone daily (P-group)
Number of subjects: 150

Group type: COMPARATOR
Intervention: No prednisolone (NoP-group)
Number of subjects: 150
Study: 16293793

Group type: EXPERIMENTAL
Intervention: 81 mg daily aspirin
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 325 mg daily aspirin
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 650 mg daily aspirin
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 15552351

Group type: EXPERIMENTAL
Intervention: Emotional words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Categorized neutral words
Number of subjects: 0

Group type: COMPARATOR
Intervention: Random neutral words
Number of subjects: 0
Study: 11430539

Group type: EXPERIMENTAL
Intervention: 0.3 U/kg daily of human recombinant GH
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard ICU treatment
Number of subjects: 22
Study: 9806703

Group type: EXPERIMENTAL
Intervention: Albuterol (2 puffs via metered dose inhaler)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo (2 puffs via metered dose inhaler)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups (smokers and nonsmokers)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups (albuterol-treated and untreated)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Both groups (overall)
Number of subjects: 68
Study: 8311204

Group type: EXPERIMENTAL
Intervention: Propofol infusion anaesthesia (induced with propofol 2.5 mg.kg‐1 and maintained with propofol 12 mg.kg‐1 x h‐1 and 30% O2 in air)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Thiopentone anaesthesia (induced with thiopentone 4 mg.kg‐1 and maintained with 70% N2O in O2)
Number of subjects: 27
Study: 2898636

Group type: EXPERIMENTAL
Intervention: 5 mg transdermal glyceryl trinitrate (GTN)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 427
Study: 31194712

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted, cell culture-derived H5N1 vaccine (7.5 μg full dose)
Number of subjects: 662

Group type: EXPERIMENTAL
Intervention: MF59-adjuvanted, cell culture-derived H5N1 vaccine (3.75 μg half dose)
Number of subjects: 662
Study: 28509725

Group type: EXPERIMENTAL
Intervention: Telmisartan 40 mg/day
Number of subjects: 1333

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) 25 mg/day
Number of subjects: 1333
Study: 25575895

Group type: EXPERIMENTAL
Intervention: Psychological methods (intervention group, 50 cases)
Number of subjects: 150

Group type: COMPARATOR
Intervention: No psychological intervention (non-intervention group, 50 cases)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Non-stent group (50 cases)
Number of subjects: 150
Study: 23538395

Group type: EXPERIMENTAL
Intervention: Low-volume, low-intensity training (LTP) for 6 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: High training volume, intensity, and frequency (HTP)
Number of subjects: 15
Study: 22014144

Group type: EXPERIMENTAL
Intervention: Dynamic Stretching (DS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Static Stretching (SS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control
Number of subjects: 18
Study: 19894369

Group type: EXPERIMENTAL
Intervention: Topical vitamin K oxide gel
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 20
Study: 16858218

Group type: EXPERIMENTAL
Intervention: Treadmill training (3 times a week for 3 months, 1 hour per session at 85% of pain-free walking time)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Treadmill training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 12917836

Group type: EXPERIMENTAL
Intervention: Volume data
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Diameter data
Number of subjects: 82
Study: 10699777

Group type: EXPERIMENTAL
Intervention: Pediatric colonoscope (Olympus PCF‐100)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Adult colonoscope (Olympus CF‐100L)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overall (including switching colonoscopes)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Pediatric colonoscope in women with prior hysterectomy
Number of subjects: 150
Study: 9234051

Group type: EXPERIMENTAL
Intervention: lorazepam (1 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 8210308

Group type: EXPERIMENTAL
Intervention: Transoesophageal cardioversion (30, 50, 100 J delivered via oesophageal electrode)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Transchest cardioversion (50, 100, 200, 360 J delivered if required)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Transoesophageal cardioversion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Transchest cardioversion
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Transoesophageal cardioversion (energies ≤ 100 J)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Transchest cardioversion (energies ≤ 100 J)
Number of subjects: 100
Study: 2434976

Group type: EXPERIMENTAL
Intervention: 4 ml of 0.5% tetracaine with 5% Trendelenburg position for 45 s
Number of subjects: 80

Group type: COMPARATOR
Intervention: 3 ml of 0.5% bupivacaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: 4 ml of 0.5% bupivacaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 4 ml of 0.5% tetracaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80
Study: 31752648

Group type: EXPERIMENTAL
Intervention: Change of reference (context of more attractive or less attractive images)
Number of subjects: 0
Study: 31430733

Group type: EXPERIMENTAL
Intervention: Advanced randomized optimization algorithms for PET reconstruction using non-smooth priors.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of about ten projections and backprojections in the PET reconstruction process.
Number of subjects: 0
Study: 28176547

Group type: EXPERIMENTAL
Intervention: Implementation intentions (IIs)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Rehearsal (RR) encoding strategy
Number of subjects: 62
Study: 26391356

Group type: EXPERIMENTAL
Intervention: QoL improvement pattern (24 patients, 6%)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: QoL stability pattern (171 patients, 41%)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: QoL deterioration pattern (78 patients, 19%)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: QoL deterioration pattern (143 patients, 34%)
Number of subjects: 416
Study: 23336628

Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (≥180 sec)
Number of subjects: 382

Group type: COMPARATOR
Intervention: Early cord clamping (≤10 sec)
Number of subjects: 382
Study: 20359723

Group type: EXPERIMENTAL
Intervention: +LCPUFA group
Number of subjects: 60

Group type: COMPARATOR
Intervention: -LCPUFA group
Number of subjects: 60
Study: 19408058

Group type: EXPERIMENTAL
Intervention: Relationship-based intervention by primary care physicians (PCPs) including cognitive-behavioral, pharmacological, and patient-centered management over 12 months with seven scheduled visits
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Relationship-based intervention by primary care physicians (PCPs)
Number of subjects: 30
Study: 17869598

Group type: EXPERIMENTAL
Intervention: 0.2% GTN ointment
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lignocaine ointment
Number of subjects: 50
Study: 15638067

Group type: EXPERIMENTAL
Intervention: Topical comfrey product Traumaplant (10% active ingredient)
Number of subjects: 203

Group type: COMPARATOR
Intervention: 1% comfrey product (control)
Number of subjects: 203
Study: 11846008

Group type: COMPARATOR
Intervention: Placebo (bakers yeast)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Erythropoietin (EPO; 3 times a week with 2,000 U after each HD session)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Se‐rich yeast (300 microg 3 times a week after each HD)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Se‐rich yeast plus EPO (300 microg Se and 2,000 U EPO 3 times a week after each HD)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 58
Study: 9670383

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at four acupoints (Chung Chi CV3, Kuan Yuan CV4, bilateral Tzu Liao UB32) plus conventional intermittent catheterization program (ICP)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional bladder training program with ICP only
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Electroacupuncture within 3 weeks after injury
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Electroacupuncture after 3 weeks after injury
Number of subjects: 80
Study: 8149361

Group type: EXPERIMENTAL
Intervention: Buspirone (10 mg orally, twice a day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3243175

Group type: EXPERIMENTAL
Intervention: Furadantine MC 100 mg tid
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Uridurine 100 mg tid
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Urfadyn PL 100 mg bid
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Furadantine MC 100 mg qid
Number of subjects: 16